Memorial Sloan Kettering Cancer Center
This study is being done to see the long-term results for patients who choose to have surgery for lymphedema (with the vascularized lymph node transfer), compared to patients who choose not to have surgery.
Inclusion Criteria: * Patients aged 18-80 years * Primary and secondary lymphedema of the upper or lower extremity * International Society of Lymphology (ISL) Stage 1, 2, or 3 lymphedema * Proficiency in English language Exclusion Criteria: * Patients with clotting disorders, venous insufficiency, end-stage lymphedema unless they are on the non-surgical arm. * Additionally, if the patient refuses to complete questionnaires, the patient will be excluded from the study and replaced at the discretion of the principal or co-principal investigator.
Upper Limb Lymphedema (ULL-27), Lymphedema Life Impact Scale, version 2 (LLISv2), LYMQOL-Leg.
Verify or correct the compensation shown for this listing.